Avid Bioservices, Inc. (CDMO) Social Stream



Avid Bioservices, Inc. (CDMO): $16.31

0.98 (+6.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Avid Bioservices Inc (CDMO) Price Targets From Analysts

Use the tables below to see what analysts covering Avid Bioservices Inc think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-01 4 $29 $27 $28.333 $21.55 31.48%
2021-10-14 4 $29 $27 $28.25 $21.55 31.09%
2021-12-08 4 $35 $29 $32 $21.55 48.49%
2022-01-03 3 $35 $31 $32.666 $21.55 51.58%

The Trend in the Analyst Price Target


CDMO's average price target has moved up $11.17 over the prior 37 weeks.

Over the past 38 weeks, CDMO's average upside potential has been 19.77%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-17 1 22 21 21.500 19.16 12.21%
2021-07-29 1 29 27 28.250 26.09 8.28%
2021-08-28 1 29 27 28.250 24.16 16.93%
2021-09-19 1 29 27 28.250 20.98 34.65%
2022-01-03 3 35 31 32.666 27.73 17.8%

CDMO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 2 0 1 0 0 3

The Trend in the Broker Recommendations


Over the past 44 weeks, CDMO's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for CDMO as an investment opportunity.

  • In the context of all US stocks, Avid Bioservices Inc's variance in analysts' estimates is lower than 35.51% of them.
  • CDMO has a higher number of analysts covering the stock than 87.46% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Avid Bioservices Inc's upside potential (average analyst target price relative to current price) is greater than 97.53% of them.
  • In the context of stocks in the small market cap category, Avid Bioservices Inc's average analyst price target is higher than 345.76% of them.

In the Pharmaceutical Products industry, CBIO, CBAY, and CARA are the three stocks most similar to Avid Bioservices Inc regarding the price target and analyst recommendation information presented here.

Is CDMO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.534 seconds.